Christiansen C - Search Results

1

Intermittent cyclic tiludronate in the treatment of osteoporosis.

Reginster JY, Christiansen C, Roux C, Fechtenbaum J, Rouillon A, Tou KP. Reginster JY, et al. Among authors: christiansen c. Osteoporos Int. 2001;12(3):169-77. doi: 10.1007/s001980170126. Osteoporos Int. 2001. PMID: 11315234 Clinical Trial.

2

Design for an ipriflavone multicenter European fracture study.

Reginster JY, Bufalino L, Christiansen C, Devogelaer JP, Gennari C, Riis BJ, Roux C. Reginster JY, et al. Among authors: christiansen c. Calcif Tissue Int. 1997;61 Suppl 1:S28-32. doi: 10.1007/s002239900382. Calcif Tissue Int. 1997. PMID: 9263614 Clinical Trial.

3

A 2-year phase II study with 1-year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis.

Clemmesen B, Ravn P, Zegels B, Taquet AN, Christiansen C, Reginster JY. Clemmesen B, et al. Among authors: christiansen c. Osteoporos Int. 1997;7(5):488-95. doi: 10.1007/pl00004152. Osteoporos Int. 1997. PMID: 9425508 Clinical Trial.

4

Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.

Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, Gennari C, Reginster JY; Ipriflavone Multicenter European Fracture Study. Alexandersen P, et al. Among authors: christiansen c. JAMA. 2001 Mar 21;285(11):1482-8. doi: 10.1001/jama.285.11.1482. JAMA. 2001. PMID: 11255425 Clinical Trial.

5

Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I.

Reginster JY, Henrotin Y, Christiansen C, Gamwell-Henriksen E, Bruyere, Collette J, Christgau S. Reginster JY, et al. Among authors: christiansen c. Calcif Tissue Int. 2001 Sep;69(3):130-7. doi: 10.1007/s002230020042. Calcif Tissue Int. 2001. PMID: 11683527 Free article.

6

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.

Reginster JY, Adami S, Lakatos P, Greenwald M, Stepan JJ, Silverman SL, Christiansen C, Rowell L, Mairon N, Bonvoisin B, Drezner MK, Emkey R, Felsenberg D, Cooper C, Delmas PD, Miller PD. Reginster JY, et al. Among authors: christiansen c. Ann Rheum Dis. 2006 May;65(5):654-61. doi: 10.1136/ard.2005.044958. Epub 2005 Dec 8. Ann Rheum Dis. 2006. PMID: 16339289 Free PMC article. Clinical Trial.

7

Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.

Reginster JY, Christiansen C, Dequinze B, Deroisy R, Gaspard U, Taquet AN, Franchimont P. Reginster JY, et al. Among authors: christiansen c. Calcif Tissue Int. 1993 Jul;53(1):13-6. doi: 10.1007/BF01352008. Calcif Tissue Int. 1993. PMID: 8394191 Clinical Trial.

8

Recommendations for the health economics analysis to be performed with a drug to be registered in prevention or treatment of osteoporosis.

Dere W, Avouac B, Boers M, Buxton M, Christiansen C, Dawson A, Gennari C, Guillemin F, Lawaetz H, Ornskov F, Roumagnac I, Reginster JY. Dere W, et al. Among authors: christiansen c. Calcif Tissue Int. 1998 Aug;63(2):93-7. doi: 10.1007/BF03322783. Calcif Tissue Int. 1998. PMID: 9685510 Review. No abstract available.

9

Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis.

Bjarnason NH, Sarkar S, Duong T, Mitlak B, Delmas PD, Christiansen C. Bjarnason NH, et al. Among authors: christiansen c. Osteoporos Int. 2001;12(11):922-30. doi: 10.1007/s001980170020. Osteoporos Int. 2001. PMID: 11808544 Clinical Trial.

10

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study.

Delmas PD, Recker RR, Chesnut CH 3rd, Skag A, Stakkestad JA, Emkey R, Gilbride J, Schimmer RC, Christiansen C. Delmas PD, et al. Among authors: christiansen c. Osteoporos Int. 2004 Oct;15(10):792-8. doi: 10.1007/s00198-004-1602-9. Epub 2004 Apr 8. Osteoporos Int. 2004. PMID: 15071723 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,602 results

Search Page

Filters